SECONDARY PREVENTION OF CORONARY-DISEASE WITH LIPID-LOWERING DRUGS

被引：0
作者：
不详
机构：
来源：
LANCET | 1989年 / 1卷 / 8636期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：473 / 474
页数：2
相关论文
共 50 条
  • [31] Lipid-lowering drugs
    Pahan, K.
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2006, 63 (10) : 1165 - 1178
  • [32] Efficacy and safety of lipid-lowering drugs in primary and secondary prevention of cardiovascular diseases in the elderly
    Ushkalova, E. A.
    Tkacheva, O. N.
    Runikhina, N. K.
    Chukhareva, N. A.
    Bevz, A. Yu.
    [J]. RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2016, 12 (03) : 351 - 358
  • [33] EFFICACY AND SAFETY OF LIPID-LOWERING DRUGS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES IN THE ELDERLY
    Martsevich, S. Y.
    [J]. RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2011, 7 (05) : 2 - 72
  • [34] Prevention of cardiovascular disease: Plea for a rationale use of diet and lipid-lowering drugs
    Scheen, AJ
    [J]. ACTA CLINICA BELGICA, 2003, 58 (03) : 149 - 151
  • [35] LIPOPROTEIN(A) PREDICTS CORONARY-DISEASE SEVERITY AMONG HYPERLIPIDEMIC MEN, AND RESPONDS TO LIPID-LOWERING THERAPY
    LIN, JT
    BROWN, BG
    ADOLPHSON, JL
    ALBERS, JJ
    [J]. ARTERIOSCLEROSIS, 1988, 8 (05): : A576 - A577
  • [36] Lipid-lowering and secondary prevention of cardiovascular disease in vascular surgical in-patients
    Froehlich, JB
    Cote, M
    Singh, MJ
    Nelson, PR
    Rohrer, MJ
    Cutler, BS
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 252A - 252A
  • [37] Early, Intensive and Persistent Lipid-Lowering Therapy for Secondary Prevention of Acute Coronary Syndrome
    Okada, Kozo
    Haze, Tatsuya
    Kikuchi, Shinnosuke
    Kirigaya, Hidekuni
    Hanajima, Yohei
    Tsutsumi, Katsuhiko
    Kirigaya, Jin
    Nakahashi, Hidefumi
    Gohbara, Masaomi
    Kimura, Yuichiro
    Kosuge, Masami
    Ebina, Toshiaki
    Sugano, Teruyasu
    Hibi, Kiyoshi
    [J]. JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2024, 31 (12) : 1748 - 1762
  • [38] The use of lipid-lowering therapy for secondary prevention in patients undergoing percutaneous coronary intervention
    Ma, JM
    Jackevicius, CA
    Dzavik, V
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2006, 22 (05) : 419 - 423
  • [39] Lipid-lowering trials in the primary and secondary prevention of coronary heart disease: New evidence, implications and outstanding issues
    Watts, GF
    Burke, V
    [J]. CURRENT OPINION IN LIPIDOLOGY, 1996, 7 (06) : 341 - 355
  • [40] Lipid-lowering drugs and homocysteine - A comparison between statins and other lipid-lowering drugs
    Jankowski, P
    Kawecka-Jaszcz, K
    [J]. ATHEROSCLEROSIS, 2004, 172 (01) : 191 - 194
12345